Semaglutide reduces risk of major cardiovascular events by 20%, finds study. Wise J. BMJ 2023;383:p2668.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wise J. Semaglutide reduces risk of major cardiovascular events by 20%, finds study. BMJ 2023;383:p2668.
PMID: 37957004